Accelerate Your Research and Development!
Are you currently facing challenges in accurately detecting and quantifying Angiotensin-Converting Enzyme (ACE) in complex biological matrices, or struggling to develop highly sensitive immunoassays for cardiovascular research and disease diagnostics? Our ACE Specific Antibody Products from Creative Biolabs help you achieve precise and reliable ACE detection, enabling robust research into its physiological roles and pathological implications through advanced immunoassay tools and high-specificity antibodies.
Contact our team to get an inquiry now!
Angiotensin-Converting Enzyme (ACE), also known as kininase II, is a crucial zinc metalloprotease that plays a central role in regulating blood pressure and fluid balance within the body. It is a key component of the Renin-Angiotensin System (RAS), a complex hormonal system vital for cardiovascular and renal homeostasis.
Structurally, ACE exists in two primary isoforms: somatic ACE (sACE), found ubiquitously in endothelial cells, epithelial cells, and macrophages, and germinal ACE (gACE), found exclusively in male reproductive tissues. Somatic ACE is a large, two-domain protein, with each domain possessing an active catalytic site. ACE's principal role involves catalyzing angiotensin I (decapeptide) into angiotensin II, a biologically active octapeptide vasoconstrictor. Concurrently, ACE inactivates bradykinin, a powerful vasodilator, thereby contributing to increased blood pressure. This dual action makes ACE a critical regulator of vascular tone and electrolyte balance.
Fig. 1 Angiotensin-converting enzyme (ACE) and ACE-secretase.1,3
ACE activity imbalance contributes to multiple disorders, like hypertension, a key cardiovascular risk factor. Heightened ACE function elevates angiotensin II generation while diminishing bradykinin, causing vasoconstriction, fluid accumulation, and myocardial structural changes. Thus, ACE inhibitors are commonly administered therapeutics for controlling hypertension, cardiac insufficiency, and diabetic kidney disease. Apart from its canonical function in the RAS, new studies emphasize angiotensin-converting enzyme 2 (ACE2), an ACE homolog. Contrasting ACE, ACE2 chiefly transforms angiotensin II into angiotensin (1-7), a vasodilatory protective peptide. ACE2 additionally functions as the principal entry receptor for SARS-CoV-2, the COVID-19-causing virus, highlighting its wider physiological and pathological significance. Deciphering the complex equilibrium and interaction between ACE and ACE2 is vital for progressing research in cardiovascular wellness, renal performance, and infectious pathologies.
Antibodies specifically targeting Angiotensin-Converting Enzyme (ACE) are indispensable tools for a broad spectrum of research, diagnostic, and potentially therapeutic applications. These antibodies are developed to bind with high affinity and specificity to the ACE molecule, allowing for its precise detection, quantification, and characterization in various biological samples.
Fig. 2 The domain structure of ACE2 and collectrin.2,3
Applications of ACE Specific Antibodies:
Creative Biolabs’ ACE Specific Antibody Products are rigorously validated across multiple species, including human, mouse, rat, bovine, and canine, ensuring broad applicability and reliable results across diverse research models. Our ACE Specific Antibody Products are designed to provide you with superior tools for your research and diagnostic needs.
Key advantages of collaborating with Creative Biolabs:
A: These antibodies are highly versatile for cardiovascular research, enabling precise detection and quantification of Angiotensin-Converting Enzyme (ACE) in various tissues and biofluids. They are commonly used in Western Blotting to assess protein expression, in Immunohistochemistry and Immunofluorescence for cellular localization studies within cardiac and vascular tissues, and in ELISA-based assays for measuring circulating ACE levels, which can be indicative of cardiovascular health or disease progression.
A: Our antibodies are meticulously developed and validated to ensure high specificity for ACE, with minimal or no cross-reactivity to ACE2. This is achieved through careful antigen selection and rigorous screening processes, which include testing against both ACE and ACE2 proteins. This specificity is crucial for researchers needing to distinguish the distinct roles of these two enzymes in the Renin-Angiotensin System and in diseases like COVID-19.
A: While primarily designed for detection and quantification, some of our ACE antibodies may possess neutralizing properties that can inhibit ACE enzymatic activity. Researchers interested in functional blocking studies should inquire about specific antibody clones validated for such applications. These antibodies can be valuable tools for investigating the physiological consequences of ACE inhibition in cellular or animal models.
A: Our ACE antibodies are validated for use with a broad range of biological samples, including human, mouse, and rat tissues (e.g., lung, kidney, heart, brain), cell lysates, and biological fluids such as serum, plasma, and urine. Optimal sample preparation protocols are provided to ensure the best performance across different sample types and applications.
A: Antibody-based detection provides direct measurement of the ACE protein, offering insights into its expression levels and localization, which may not always correlate directly with enzymatic activity. While activity assays measure the functional capacity of the enzyme, antibody-based methods offer high specificity, sensitivity, and throughput, making them ideal for screening, biomarker identification, and detailed protein characterization. Combining both approaches can provide a comprehensive understanding of ACE's role.
Access the Creative Biolabs Edge – Request Your Quote Now
REFERENCES
Anti-ACE Neutralizing Antibody (V3S-0622-YC594) (CAT#: V3S-0622-YC594)
Target: ACE
Host Species: Human
Target Species: Human,
Application: FuncS,